Close
Almac
Achema middle east

Malvern, Purdue collaborate to advance nanotechnology

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Novartis to Lower Innovative Medicines Price in the US

Novartis, which is a leading global innovative medicines company,...

New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices

President Donald Trump on December 19, 2025, said that...
- Advertisement -

Malvern Instruments and Birck Nanotechnology Center at Purdue University have enterted into collaboration to examine the application of light scattering techniques in the characterization of nanoparticles and advance nanotechnology.

The collaboration is formed for scientists who manufacture nanoparticles and for those who work with biomolecule applications and liposome in the area of drug delivery.

The companies are focused on the application of chromatography, dynamic light scattering, static light scattering and electrophoretic light scattering in the characterization of nanoparticles.

The application includes molecular weight determination, biomolecular structure and stability, suspension stability, micelle formation and surface interaction.

Latest stories

Related stories

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Novartis to Lower Innovative Medicines Price in the US

Novartis, which is a leading global innovative medicines company,...

New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices

President Donald Trump on December 19, 2025, said that...

First GLP-1 Pill for Obesity by Novo Nordisk Approved by FDA

The U.S. Food and Drug Administration – FDA on...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »